DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications.

Curr Issues Mol Biol · 2025 · PMC12026360 · PMID 40699626

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a pilot study involving 33 patients with intermediate-2 and high-risk MF, patients harboring JAK2V617F, SF3B1, or U2AF1 mutations showed a trend of a better response to treatment, whereas those with the ASXL1 mutation, often associated with poor prognosis, showed a limited benefit.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.